Top

Cardiovascular Intervention and Therapeutics

Published in:

Open Access 01-10-2018 | Review Article

Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

Authors: Osami Kawarada, Kan Zen, Koji Hozawa, Shinobu Ayabe, Hsuan-Li Huang, Donghoon Choi, Su Hong Kim, Jiyoun Kim, Taku Kato, Yoshinori Tsubakimoto, Tasuya Nakama, Shigeo Ichihashi, Naoki Fujimura, Akihiro Higashimori, Masahiko Fujihara, Tomoyasu Sato, Bryan Ping-Yen Yan, Skyi Yin-Chun Pang, Chumpol Wongwanit, Yew Pung Leong, Benjamin Chua, Robbie K. George, Yoshiaki Yokoi, Hisashi Motomura, Hideaki Obara

Published in: Cardiovascular Intervention and Therapeutics | Issue 4/2018

Abstract

The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.

Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–40.CrossRef

Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.CrossRef

Prasad N, Jha V. Hemodialysis in Asia. Kidney Dis (Basel). 2015;1:165–77.CrossRef

Kawarada O, Yasuda S, Huang J, et al. Contemporary infrapopliteal intervention for limb salvage and wound healing: harmonization of revascularization and wound management. Circ J. 2014;78:1540–9.CrossRef

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–81.CrossRef

Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108:1527–32.CrossRef

Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004;19:59–66.CrossRef

Ndip A, Jude EB. Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Extrem Wounds. 2009;8:82–94.CrossRef

Kawarada O, Fujihara M, Higashimori A, et al. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. 2012;80:861–71.CrossRef

10.

Kawarada O, Yokoi Y, Higashimori A, et al. Impact of end-stage renal disease in patients with critical limb ischaemia undergoing infrapopliteal intervention. EuroIntervention. 2014;10:753–60.CrossRef

11.

Conte MS. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Vasc Surg. 2010;52:96S–103S.CrossRef

12.

Azuma N, Kikuchi S, Okuda H, Miyake K, Koya A. Recent progress of bypass surgery to the dialysis-dependent patients with critical limb ischemia. Ann Vasc Dis. 2017;10:178–84.CrossRef

13.

Cheng SWK. Endovascular practice in Asia–Pacific. In: Fogarty TJ, White RA, editors. Peripheral endovascular interventions. 3rd ed. Berlin: Springer; 2010. p. 471–7.CrossRef

14.

Silvestro A, Diehm N, Savolainen H, et al. Falsely high ankle–brachial index predicts major amputation in critical limb ischemia. Vasc Med. 2006;11:69–74.CrossRef

15.

Padberg FT, Back TL, Thompson PN, et al. Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischemic extremity. J Surg Res. 1996;60:365–9.CrossRef

16.

Tsai FW, Tulsyan N, Jones DN, et al. Skin perfusion pressure of the foot is a good substitute for toe pressure in the assessment of limb ischemia. J Vasc Surg. 2000;32:32–6.CrossRef

17.

Shimazaki M, Matsuki T, Yamauchi K, et al. Assessment of lower limb ischemia with measurement of skin perfusion pressure in patients on hemodialysis. Ther Apher Dial. 2007;11:196–201.CrossRef

18.

Yamada T, Ohta T, Ishibashi H, et al. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs—comparison with other noninvasive diagnostic methods. J Vasc Surg. 2008;47:318–23.CrossRef

19.

Castronuovo JJ Jr, Adera HM, Smiell JM, et al. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg. 1997;26:629–37.CrossRef

20.

Kawarada O, Yokoi Y, Higashimori A, et al. Assessment of macro- and microcirculation in contemporary critical limb ischemia. Catheter Cardiovasc Interv. 2011;78:1051–8.CrossRef

21.

Suzuki K. How to diagnose peripheral arterial disease. Podiatry Today. 2007;4:54–65.

22.

Okamoto K, Oka M, Maesato K, et al. Peripheral arterial occlusive disease is more prevalent in patients with hemodialysis: comparison with the findings of multidetector-row computed tomography. Am J Kidney Dis. 2006;48:269–76.CrossRef

23.

Weinberg I, Jaff MR. Nonatherosclerotic arterial disorders of the lower extremities. Circulation. 2012;126:213–22.CrossRef

24.

Mintz AJ, Weinberg I. Nonatherosclerotic PAD: approach to exertional pain in the lower extremities. Curr Cardiol Rep. 2015;17:66.CrossRef

25.

Apigian AK, Landry GJ. Basic data underlying decision making in nonatherosclerotic causes of intermittent claudication. Ann Vasc Surg. 2015;29:138–53.CrossRef

26.

Perlowski AA, Jaff MR. Vascular disorders in athletes. Vasc Med. 2010;15:469–79.CrossRef

27.

Obara H, Matsubara K, Fujimura N, et al. Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease: cases series and review of the literature. Int J Angiol. 2015;24:137–42.CrossRef

28.

Kawarada O. Nonatherosclerotic peripheral artery disease. In: Yokoi Y, editor. Angiography and endovascular therapy for peripheral artery disease. London: InTech; 2017. p. 127–50.

29.

Herrick A. Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin N Am. 2008;34:89–114.CrossRef

30.

Shiba M, Ieko M, Kawarada O. Symmetric peripheral gangrene in antiphospholipid syndrome. Heart Asia. 2016;8:8.CrossRef

31.

Brière JB. Essential thrombocythemia. Orphanet J Rare Dis. 2007;2:3.CrossRef

32.

Mills JL, Conte MS, Armstrong DG, Society for Vascular Surgery Lower Extremity Guidelines Committee, et al. The Society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220–34.CrossRef

33.

Ayabe S. Strategy for diabetic foot wound management in Japan: AID concept. The 3rd conference of Association of Diabetic Foot Surgeons; Venice. 2017.

34.

Snyder RJ, Kirsner RS, Warriner RA 3rd, et al. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manag. 2010;56(4 Suppl):S1–24.

35.

Yokoi Y. How should recent endovascular trials for femoropopliteal artery disease be interpreted? Cardiovasc Interv Ther. 2017;32:106–13.CrossRef

36.

Huang HL, Chou HH, Wu TY, et al. Endovascular intervention in Taiwanese patients with critical limb ischemia: patient outcomes in 333 consecutive limb procedures with a 3-year follow-up. J Formos Med Assoc. 2014;113:688–95.CrossRef

37.

Kawarada O, Yokoi Y. Native chronic total occlusion recanalization after lower limb bypass graft occlusion: a series of nine cases. Catheter Cardiovasc Interv. 2010;76:214–9.CrossRef

38.

Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, Roffi M, Dorsaz PA, Schwarzwälder U, Bürgelin K, Macharzina R, Zeller T. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58:792–8.CrossRef

39.

Nishibe T, Maruno K, Iwahori A, Fujiyoshi T, Suzuki S, Takahashi S, Ogino H, Nishibe M. The role of common femoral artery endarterectomy in the endovascular era. Ann Vasc Surg. 2015;29:1501–7.CrossRef

40.

Bonvini RF, Rastan A, Sixt S, Beschorner U, Noory E, Schwarz T, Roffi M, Dorsaz PA, Schwarzwälder U, Bürgelin K, Macharzina R, Zeller T. Angioplasty and provisional stent treatment of common femoral artery lesions. J Vasc Interv Radiol. 2013;24:175–83.CrossRef

41.

Halpin D, Erben Y, Jayasuriya S, Cua B, Jhamnani S, Mena-Hurtado C. Management of isolated atherosclerotic stenosis of the common femoral artery: a review of the literature. Vasc Endovasc Surg. 2017;51:220–7.CrossRef

42.

Kawarada O, Sakamoto S, Harada K, et al. Contemporary crossing techniques for infrapopliteal chronic total occlusions. J Endovasc Ther. 2014;21:266–80.CrossRef

43.

Chou HH, Huang HL, Hsieh CA, et al. Outcomes of endovascular therapy with the controlled antegrade retrograde subintimal tracking (CART) or reverse CART technique for long infrainguinal occlusions. J Endovasc Ther. 2016;23:330–8.CrossRef

44.

Ichihashi S, Sato T, Iwakoshi S, et al. Technique of percutaneous direct needle puncture of calcified plaque in the superficial femoral artery or tibial artery to facilitate balloon catheter passage and balloon dilation of calcified lesions. J Vasc Interv Radiol. 2014;25:784–8.CrossRef

45.

Kawarada O, Noguchi T, Yasuda S. Longitudinal cracking with a guidewire tail for extremely calcified lesions in infrainguinal arteries: PICKING technique. Cardiovasc Interv Radiol. 2018;41:313–6.CrossRef

46.

Georgakarakos E, Papanas N, Papadaki E, et al. Endovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies. Angiology. 2013;64:583–91.CrossRef

47.

Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical application. Br J Plast Surg. 1987;40:113–41.CrossRef

48.

Neville RF, Attinger CE, Bulan EJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg. 2009;23:367–73.CrossRef

49.

Iida O, Nanto S, Uematsu M, et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010;75:830–66.PubMed

50.

Iida O, Soga Y, Hirano K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg. 2012;55:363–70.CrossRef

51.

Azuma N, Uchida H, Kokubo T, et al. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg. 2012;43:322–8.CrossRef

52.

Azuma N, Koya A, Uchida D, et al. Ulcer healing after peripheral intervention-can we predict it before revascularization? Circ J. 2014;78:1791–800.CrossRef

53.

Troisi N, Turini F, Chisci E, et al. Pedal arch patency and not direct-angiosome revascularization predicts outcomes of endovascular interventions in diabetic patients with critical limb ischemia. Int Angiol. 2017;36:438–44.PubMed

54.

Kawarada O, Yasuda S, Nishimura K, et al. Effect of single tibial artery revascularization on microcirculation in the setting of critical limb ischemia. Circ Cardiovasc Interv. 2014;7:684–91.CrossRef

55.

Higashimori A, Yokoi Y. Use of indigo carmine angiography to qualitatively assess adequate distal perfusion after endovascular revascularization in critical limb ischemia. J Endovasc Ther. 2015;22:352–5.CrossRef

56.

Rother U, Krenz K, Lang W, et al. Immediate changes of angiosome perfusion during tibial angioplasty. J Vasc Surg. 2017;65:422–30.CrossRef

57.

Kawarada O, Yokoi Y. Dorsalis pedis artery stenting for limb salvage. Catheter Cardiovasc Interv. 2008;71:976–82.CrossRef

58.

Kawarada O, Yokoi Y, Higashimori A, et al. Stent-assisted below-the-ankle angioplasty for limb salvage. J Endovasc Ther. 2011;18:32–42.CrossRef

59.

Nakama T, Watanabe N, Haraguchi T, et al. Clinical outcomes of pedal artery angioplasty for patients with ischemic wounds: results from the multicenter RENDEZVOUS registry. JACC Cardiovasc Interv. 2017;10:79–90.CrossRef

60.

Nakama T, Watanabe N, Kimura T, et al. Clinical implications of additional pedal artery angioplasty in critical limb ischemia patients with infrapopliteal and pedal artery disease. J Endovasc Ther. 2016;23:83–91.CrossRef

61.

Kawarada O. Commentary: heading for the backdoor: an extreme approach to foot salvage in CLI patients. J Endovasc Ther. 2012;19:812–4.CrossRef

62.

Kawarada O, Yokoi Y, Honda Y, et al. Awareness of anatomical variations for infrapopliteal intervention. Catheter Cardiovasc Interv. 2010;76:888–94.CrossRef

63.

Miyawaki D, Nomura T, Kubota H, et al. Successful limb salvage from critical limb ischemia with bilateral variant anatomy of infrapopliteal arteries. Cardiovasc Interv Ther. 2017. https://doi.org/10.1007/s12928-017-0505-6.CrossRefPubMed

64.

Kakehashi S, Kawarada O, Yagyu T, et al. Retrograde variant artery approach for infrapopliteal chronic total occlusion intervention. JACC Cardiovasc Interv. 2017;10:e201–3.CrossRef

Title: Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care
Authors: Osami Kawarada
Kan Zen
Koji Hozawa
Shinobu Ayabe
Hsuan-Li Huang
Donghoon Choi
Su Hong Kim
Jiyoun Kim
Taku Kato
Yoshinori Tsubakimoto
Tasuya Nakama
Shigeo Ichihashi
Naoki Fujimura
Akihiro Higashimori
Masahiko Fujihara
Tomoyasu Sato
Bryan Ping-Yen Yan
Skyi Yin-Chun Pang
Chumpol Wongwanit
Yew Pung Leong
Benjamin Chua
Robbie K. George
Yoshiaki Yokoi
Hisashi Motomura
Hideaki Obara
Publication date: 01-10-2018
Publisher: Springer Japan
Published in: Cardiovascular Intervention and Therapeutics / Issue 4/2018
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-018-0523-z

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Spontaneous rotation of the monorail-type guide extension support catheter during advancement of a curved guiding catheter: the potential hazard of twisting with the coronary guidewire

Correction to: Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan

Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry

Effect of low-density lipoprotein cholesterol on the geometry of coronary bifurcation lesions and clinical outcomes of coronary interventions in the J-REVERSE registry

Optical frequency domain imaging-guided rotational atherectomy followed by drug-coated balloon dilation to the non-calcified lesion in a patient with severe thrombocytopenia

Very late scaffold thrombosis one week after the discontinuation of dual antiplatelet therapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page